Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Donnatal Death is Beginning to Go Public
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Roller007on Jun 23, 2016 4:44pm
109 Views
Post# 24992671

RE:RE:RE:RE:RE:Donnatal Death is Beginning to Go Public

RE:RE:RE:RE:RE:Donnatal Death is Beginning to Go PublicCxrbull:  off course Twitter lit up with donnatel's risk of getting discontinued, they have to offset the upside from the Brexit issues ending.  Like you said, RBC analyst Doug always mentioned the risk of FDA pulling the drug, so nothing new here.  
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities